News

Power Medical Interventions, a manufacturer and marketer of intelligent surgical instruments, has reported a net loss applicable to common shares of $9.4m, or $0.55 per basic and diluted

China Sky One Medical has obtained production approval from the State Food and Drug Administration in China for calcium folinate injection. The company said that another two new

Xoft, a radiation oncology company, has received clearance from the FDA for a skin and surface treatment applicator for use with the Axxent electronic brachytherapy system to deliver

Pharmexa, a biotechnology company, and Affitech AS, a human therapeutic antibody discovery and engineering company, have entered into a conditional agreement to merge the two companies by means

UK-based Stem Cell Sciences has entered into a definitive agreement with StemCells, a US-based biotechnology company, for the sale of the trading subsidiaries of the company and certain

In accordance with Marketplace Rule 4310(c)(8)(C), the company has been provided a period of 90 calendar days, through June 4, 2009, to regain compliance with the Rule. The

Access Pharmaceuticals, a biopharmaceutical company, has announced positive safety and efficacy results from its Phase II monotherapy clinical study of ProLindac in late-stage, heavily pretreated ovarian cancer patients.

Tecan, a supplier of laboratory instruments and solutions, and GE Healthcare, have formed collaboration to bring increased quality and efficiency to process development. The collaboration between the two

Under the terms of the agreement, Schering-Plough shareholders will receive 0.5767 shares and $10.50 in cash for each share of Schering-Plough. Each Merck share will automatically become a